| Activation of CPP32-like caspases contributes to neuronal apoptosis and neurological dysfunction after traumatic brain injury AG Yakovlev, SM Knoblach, L Fan, GB Fox, R Goodnight, AI Faden Journal of Neuroscience 17 (19), 7415-7424, 1997 | 756 | 1997 |
| Sustained sensory/motor and cognitive deficits with neuronal apoptosis following controlled cortical impact brain injury in the mouse GB FOX, LEI Fan, RA LEVASSEUR, AI FADEN Journal of neurotrauma 15 (8), 599-614, 1998 | 375 | 1998 |
| Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl] ethyl}-benzofuran-5-yl) benzonitrile]: II. Neurophysiological characterization and broad preclinical … GB Fox, TA Esbenshade, JB Pan, RJ Radek, KM Krueger, BB Yao, ... Journal of Pharmacology and Experimental Therapeutics 313 (1), 176-190, 2005 | 303 | 2005 |
| Histamine H3 receptor antagonists: preclinical promise for treating obesity and cognitive disorders TA Esbenshade, GB Fox, MD Cowart Molecular interventions 6 (2), 77, 2006 | 218 | 2006 |
| Effects of histamine H3 receptor ligands GT-2331 and ciproxifan in a repeated acquisition avoidance response in the spontaneously hypertensive rat pup GB Fox, JB Pan, TA Esbenshade, YL Bennani, LA Black, R Faghih, ... Behavioural brain research 131 (1-2), 151-161, 2002 | 184 | 2002 |
| 4-(2-[2-(2 (R)-methylpyrrolidin-1-yl) ethyl] benzofuran-5-yl) benzonitrile and related 2-aminoethylbenzofuran H3 receptor antagonists potently enhance cognition and attention M Cowart, R Faghih, MP Curtis, GA Gfesser, YL Bennani, LA Black, L Pan, ... Journal of medicinal chemistry 48 (1), 38-55, 2005 | 159 | 2005 |
| Two novel and selective nonimidazole H3 receptor antagonists A-304121 and A-317920: II. In vivo behavioral and neurophysiological characterization GB Fox, JB Pan, RJ Radek, AM Lewis, RS Bitner, TA Esbenshade, ... Journal of Pharmacology and Experimental Therapeutics 305 (3), 897-908, 2003 | 152 | 2003 |
| The behavioral assessment of sensorimotor processes in the mouse: acoustic startle, sensory gating, locomotor activity, rotarod, and beam walking P Curzon, M Zhang, RJ Radek, GB Fox | 149 | 2011 |
| Effect of traumatic brain injury on mouse spatial and nonspatial learning in the Barnes circular maze GB FOX, L Fan, RA LeVASSEUR, AI FADEN Journal of neurotrauma 15 (12), 1037-1046, 1998 | 149 | 1998 |
| Memory consolidation induces a transient and time‐dependent increase in the frequency of neural cell adhesion molecule polysialylated cells in the adult rat hippocampus GB Fox, AW O'Connell, KJ Murphy, CM Regan Journal of neurochemistry 65 (6), 2796-2799, 1995 | 130 | 1995 |
| Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist AA Hancock, YL Bennani, EN Bush, TA Esbenshade, R Faghih, GB Fox, ... European journal of pharmacology 487 (1-3), 183-197, 2004 | 126 | 2004 |
| Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects TA Esbenshade, KM Krueger, TR Miller, CH Kang, LI Denny, DG Witte, ... Journal of Pharmacology and Experimental Therapeutics 305 (3), 887-896, 2003 | 125 | 2003 |
| Anatomic variation of the middle cerebral artery in the Sprague-Dawley rat. G Fox, D Gallacher, S Shevde, J Loftus, G Swayne Stroke 24 (12), 2087-2092, 1993 | 124 | 1993 |
| Behavioral responses of C57BL/6, FVB/N, and 129/SvEMS mouse strains to traumatic brain injury: implications for gene targeting approaches to neurotrauma GB FOX, RA LeVASSEUR, AI FADEN Journal of neurotrauma 16 (5), 377-389, 1999 | 123 | 1999 |
| Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-methylpyrrolidinyl] ethyl}-benzofuran-5-yl) benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with … TA Esbenshade, GB Fox, KM Krueger, TR Miller, CH Kang, LI Denny, ... Journal of Pharmacology and Experimental Therapeutics 313 (1), 165-175, 2005 | 122 | 2005 |
| Default-mode-like network activation in awake rodents J Upadhyay, SJ Baker, P Chandran, L Miller, Y Lee, GJ Marek, U Sakoglu, ... PloS one 6 (11), e27839, 2011 | 107 | 2011 |
| Preclinical characterization of A‐582941: A novel α7 neuronal nicotinic receptor agonist with broad spectrum cognition‐enhancing properties KR Tietje, DJ Anderson, RS Bitner, EA Blomme, PJ Brackemeyer, ... CNS neuroscience & therapeutics 14 (1), 65-82, 2008 | 102 | 2008 |
| Antidepressant-like effect of D2/3 receptor-, but not D4 receptor-activation in the rat forced swim test AM Basso, KB Gallagher, NA Bratcher, JD Brioni, RB Moreland, GC Hsieh, ... Neuropsychopharmacology 30 (7), 1257-1268, 2005 | 101 | 2005 |
| Characterization of 7-and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease F Luo, NR Rustay, U Ebert, VP Hradil, TB Cole, DA Llano, SR Mudd, ... Neurobiology of aging 33 (5), 933-944, 2012 | 100 | 2012 |
| Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2, 2, 3, 3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4, 5-dimethyl-3H-thiazol-(2Z … BB Yao, G Hsieh, AV Daza, Y Fan, GK Grayson, TR Garrison, ... Journal of Pharmacology and Experimental Therapeutics 328 (1), 141-151, 2009 | 100 | 2009 |
Chih-Liang ChinMerck在 merck.com 的电子邮件经过验证
